VB2 drags down achievement of Guangji Pharmaceutical in H1 2012

Summary: Guangji Pharmaceutical suffers a USD3.7 million loss in H1 2012 due to the depressed performance of its main product, VB2. VB2 drags down the achievement of Guangji Pharmaceutical in H1 2012On Aug. 30, 2012, Hubei Guangji Pharmaceutical Co.,...

Corn Products China News 201210

www.cnchemicals.com